1 We collected 10,892 occurrence records for 1,831 species.
2 We collected 2655 spiders from plantations and established re
3 We collected 304 (123)I-ioflupane images from 3 trials that i
4 From the video recordings,
we collected 598 offshore calls from 10 individuals in two br
5 We collected 95 dust samples from dormitory common areas and
6 We collected and analyzed data from 5766 participants in a pr
7 In particular,
we collected approximately 4200 common variants reported in g
8 We collected bile and blood samples from 50 patients undergoi
9 We collected blood samples from 3 relatives with CRC in Spain
10 We collected blood samples from 42 patients with chronic HCV
11 We collected colons from mice and performed transcriptome ana
12 In this epidemiological study,
we collected daily counts of emergency hospital visits from t
13 We collected data during August-October 2015 by conducting in
14 We collected data for prison suicides in 24 high-income count
15 We collected data from 68 eyes with intermediate AMD from 68
16 ed States has large racial, ethnic, and regional variation;
we collected data from all 50 states to better analyze change
17 For this analysis
we collected data from only participants with LRAs.
18 We collected data from patients with more than 10 colonic pol
19 ulticentre, prospective, observational, first-in-man study,
we collected data from seven tertiary care hospitals in five
20 We collected data from structured clinical neurological asses
21 We collected data from the published literature to inform mod
22 We collected data from the US Cancer Statistics registry, whi
23 We collected data on 23 genetic variants associated with risk
24 We collected data on 68,514 women (mean age, 65 +/- 7 years)
25 Additionally, between June 16, 2014, and Dec 22, 2014,
we collected data on 78 622 individuals from the 52 towns, of
26 We collected data on patient and lesion characteristics, outc
27 We collected data on patient histories, tumor phenotypes, and
28 trition in Uganda with therapeutic formulas F-75 and F-100,
we collected data on symptoms, clinical findings, plasma mark
29 From March 2010 through March 2013,
we collected data prospectively and through medical record re
30 We collected demographic, clinical, and pathology data.
31 We collected fecal and mucosal samples from adult patients wh
32 nal responses in the human superior temporal cortices (STC)
we collected fMRI data from deaf and hearing participants (ma
33 We collected genetic data for 210 New World bird species dist
34 ion of genetic and linguistic variation within populations,
we collected genetic markers and speech recordings in the adm
35 We collected HCC samples from 59 patients who underwent surgi
36 We collected information on patients' disease activity scores
37 We collected information on the fecal and mucosa-associated m
38 We collected information regarding various laboratory tests i
39 We collected liver and serum from methionine adenosyltransfer
40 We collected maternal and cord blood at delivery, measured ma
41 We collected NLFs from patients with CRSsNP (n = 33), CRSwNP
42 We collected organic carbon (OC) on quartz filters, quantifie
43 Here
we collected over 100 distinct structural probes from radioly
44 We collected publicly available expression profiles of patien
45 We collected retrospective data from 384 Chinese children and
46 We collected samples of ILD tissue (n = 45) and healthy donor
47 We collected sociodemographic, clinical and laboratory parame
48 We collected stratum corneum (SC) specimens from the volar fo
49 We collected water, hand rinse, food, soil, and fly samples f
50 We collected weekly oral swabs from young children and mother